Innovate UK

Operator of a material innovation company intended to develop a thin bio-plastic coating for paper and card that replaces fossil fuel plastics in packaging for food, drink, cosmetics, and personal care. The company's coating is made from renewable feedstocks, particularly compostable seaweed, and marine-safe, paper and card packaging coated with biomaterial has been certified recyclable, enabling users to eliminate the need for single-use plastics.

Datalase Ltd. specializes in developing materials for laser coding and marking across various industries, including pharmaceuticals, food and beverage, electronics, cosmetics, and tobacco. The company's innovative ink solutions enable high-speed, in-line digital printing, allowing for the customization of packaging with variable information such as date and lot codes, barcodes, and graphics. Datalase's proprietary technology is designed for use on outercases, products, and primary packaging, enhancing quality and operational efficiency for brand owners. The company operates through a partner network in Europe, the United States, and Asia, and has established strategic partnerships with key industry players. Founded in 1987 and based in Widnes, United Kingdom, Datalase was previously known as Sherwood Technology Ltd. before rebranding in 2006.

Mimica Lab Ltd., established in 2017 and based in London, develops innovative freshness indicators for perishable products, including food and pharmaceuticals. The company's flagship product, Mimica Touch, features a patented label or cap that becomes bumpy to signal when a product is no longer safe for consumption, based on real-time temperature conditions. This tactile interface provides a clear indication of freshness calibrated to various food types, addressing the critical issue of food waste, which affects a significant portion of global food production. Research suggests that utilizing Mimica Touch could lead to a 50% reduction in retail food waste and a 60% decrease in waste at home. By improving food safety and efficiency, Mimica aims to prevent millions of tonnes of food from being discarded, thereby contributing to a more sustainable food system.

HIVED is building the mass-market parcel delivery network of the future by leveraging vertical integration, operational process innovation and software. HIVED has developed a system that is significantly better than the status quo in every way imaginable: more efficient (and therefore more affordable), better for people (no gig-economy, fully employed staff) and the environment (100% emission-free end-to-end, no offsetting ever) as well as providing the best possible delivery experience.

Symbiosis Pharmaceutical Services was established in 2011 in response to increasing global demand for niche, sterile manufacturing specialists that could satisfy product supply needs for clinical trials. We created our purpose-built facility in Stirling, Scotland, specifically designed with biologic and small molecule production capabilities in mind to support biotech and speciality pharmaceutical companies worldwide that require small-scale injectable products. Differing from most CMOs, from the day our operations commenced we offered rapid access to manufacturing slots and quick release of drug products to ensure tight timelines are successfully met. Naturally, this has been a real hit with our clients.

Skipping Rocks Lab is a London-based startup that develops natural and biodegradable packaging for liquids made from seaweed extract. It has developed Ooho!, an edible water bottle alternative to plastic bottles. Skipping Rocks Lab was co-founded by graduates from Imperial College and Royal College of Art and is currently incubated in the Climate KIC accelerator.

Symbiosis Pharmaceutical Services was established in 2011 in response to increasing global demand for niche, sterile manufacturing specialists that could satisfy product supply needs for clinical trials. We created our purpose-built facility in Stirling, Scotland, specifically designed with biologic and small molecule production capabilities in mind to support biotech and speciality pharmaceutical companies worldwide that require small-scale injectable products. Differing from most CMOs, from the day our operations commenced we offered rapid access to manufacturing slots and quick release of drug products to ensure tight timelines are successfully met. Naturally, this has been a real hit with our clients.

Symbiosis Pharmaceutical Services was established in 2011 in response to increasing global demand for niche, sterile manufacturing specialists that could satisfy product supply needs for clinical trials. We created our purpose-built facility in Stirling, Scotland, specifically designed with biologic and small molecule production capabilities in mind to support biotech and speciality pharmaceutical companies worldwide that require small-scale injectable products. Differing from most CMOs, from the day our operations commenced we offered rapid access to manufacturing slots and quick release of drug products to ensure tight timelines are successfully met. Naturally, this has been a real hit with our clients.